Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: A narrative review

Table 2 Details of the mediastinal lymph node metastasis for the patients in Table 1

LN location		Metastasis rate (%)
Upper mediastinum	Upper thoracic paraesophageal LN	8.5	(3/35)
	Left recurrent nerve LN	15.2	(5/33)
	Right recurrent nerve LN	20.6	(7/34)
	Left trachebronchial LN	17.4	(4/23)
Meddle mediastinum	Subcranial LN	18.2	(6/33)
	Middle thoracic paraesophageal LN	20.0	(7/35)
	Left main bronchus LN	12.9	(4/31)
	Right main bronchus LN	16.2	(5/31)
Lower mediastinum	Lower thoracic paraesophageal LN	17.1	(6/35)
	Supradiaphragmatic LN	13.3	(4/30)
	Posterior mediastinal LN	17.2	(5/29)

Number of patients with metastasis/number of patients who underwent lymph node dissection is indicated in each parenthesis. LN: Lymph node.